Abstract | OBJECTIVE: METHODS: Patients with chronic low back pain were randomly divided into 2 groups treated either with oral ibuprofen-arginine (400 mg) or with placebo. Blood was drawn from study subjects before, during, and after treatment and they were asked each time about the intensity of their pain. Concentrations of nitric oxide (NO) metabolites were determined. RESULTS: Twenty minutes after intake of ibuprofen-arginine, but not after placebo, there was a relevant and significant reduction of NO metabolites in serum. In both groups there was significant analgesic effect compared to baseline. CONCLUSION:
|
Authors | Haiko Sprott, Renate E Gay, Beat A Michel, Steffen Gay |
Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 33
Issue 12
Pg. 2515-8
(Dec 2006)
ISSN: 0315-162X [Print] Canada |
PMID | 17013995
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Analgesics
- Drug Combinations
- Nitric Oxide
- Arginine
- Ibuprofen
- ibuprofen arginine
|
Topics |
- Analgesics
(therapeutic use)
- Arginine
(therapeutic use)
- Chronic Disease
- Drug Combinations
- Female
- Humans
- Ibuprofen
(therapeutic use)
- Low Back Pain
(blood, drug therapy, physiopathology)
- Male
- Middle Aged
- Nitric Oxide
(blood)
- Pain Measurement
- Pilot Projects
- Single-Blind Method
- Treatment Outcome
|